Prevalence, clinical impact and associated patient-centred outcomes of advance directives in Swiss intensive care units: Results from the retrospective ADVISE Study
Authors:
- Sira Maria BaumannSBSira Maria Baumann
- Dominik VockDVDominik Vock
- Simon A. AmacherSASimon A. Amacher
- Yasmin ErneYEYasmin Erne
- Pascale GrzonkaPGPascale Grzonka
- Sebastian BergerSBSebastian Berger
- Martin LohriMLMartin Lohri
- Sabina HunzikerSHSabina Hunziker
- Mathias NebikerMNMathias Nebiker
- Luca CioccariLCLuca Cioccari
Open Access
- 1 September 2025
- journal article
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 155 (9) , 4625
Abstract
STUDY AIMS: Data on the usefulness of advance directives for end-of-life decision-making in intensive care units (ICUs) are scarce. The primary aim of the present study was to investigate the prevalence of advance directives in patients of two Swiss ICUs. To contextualise how advance directives are created, interpreted and translated into clinical practice and which patient profiles influence whether and how patients choose to formulate advance directives, secondary objectives included analysing their content, clinical translation, and associated patient characteristics and outcomes. METHODS: The retrospective cohort study was carried out at two tertiary Swiss ICUs.Data were collected from patients with advance directives treated in ICUs >48 hours from 2020 to 2022.The primary endpoint was the prevalence of advance directives and their content regarding life-prolonging measures, including cardiopulmonary resuscitation (CPR). RESULTS: Of the 5242 patients included, 313 (6.0%) had advance directives. While 290/313 (92.7%) consented to life-prolonging measures other than CPR, CPR was less frequently desired (217/313 [69.3%]). 14.0% (18/129) requested CPR despite declining life-prolonging measures. Fewer women consented to life-prolonging measures and/or CPR than men, whereas prior ICU stays were associated with higher consent rates. Of 104 treatment adaptations, 53 (51.0%) aligned with advance directives, while 33/104 adaptations (31.7%) were based on presumed poor prognosis and 4/104 (3.9%) on surrogate decisions. While patients declining life-prolonging measures experienced faster treatment changes, survival and functional outcomes did not differ based on consent status. CONCLUSIONS:The prevalence of patients with advance directives admitted to Swiss ICUs is low, and substantial obstacles must be overcome in clinical practice. Inconsistent or contradictory contenthighlightsa need for better preemptive communication and documentation of patients’ wishes. Respecting patient autonomy in choosing to forgo life-prolonging measures might not be associated with a lower likelihood of survival or functional outcomes. Trial registration: https://clinicaltrials.gov NCT04348318.Keywords
This publication has 34 references indexed in Scilit:
- Advance directives in the intensive care unit: An eight-year vanguard cohort studyJournal of Critical Care, 2024
- Survival ≠ RecoveryCHEST Critical Care, 2023
- Global Comparison of Communication of End-of-Life Decisions in the ICUChest, 2022
- Assessment of Variability in End-of-Life Care Delivery in Intensive Care Units in the United StatesJAMA Network Open, 2019
- Medical End-of-Life Practices in SwitzerlandJAMA Internal Medicine, 2016
- Are written advance directives helpful to guide end-of-life therapy in the intensive care unit? A retrospective matched-cohort studyJournal of Critical Care, 2014
- Development and Validation of the Good Outcome Following Attempted Resuscitation (GO-FAR) Score to Predict Neurologically Intact Survival After In-Hospital Cardiopulmonary ResuscitationJAMA Internal Medicine, 2013
- Interventions to promote the use of advance directives: An overview of systematic reviewsPatient Education and Counseling, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987